Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy

Background and objectives: To find out the response to growth hormone therapy among growth hormone deficiency patients with different causes and to find out the role of insulin-like growth factor one in monitoring response. Methods: This retrospective study was done on fifty patients who receive...

Full description

Saved in:
Bibliographic Details
Main Authors: Kawes Omer Zangana, Zaher Taher Gardi, Dawand Dlshad Abdulla
Format: Article
Language:English
Published: Kurdistan Higher Council Of Medical Specialties 2023-03-01
Series:Advanced Medical Journal
Subjects:
Online Access:https://amj.khcms.edu.krd/index.php/main/article/view/130
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849698765767704576
author Kawes Omer Zangana
Zaher Taher Gardi
Dawand Dlshad Abdulla
author_facet Kawes Omer Zangana
Zaher Taher Gardi
Dawand Dlshad Abdulla
author_sort Kawes Omer Zangana
collection DOAJ
description Background and objectives: To find out the response to growth hormone therapy among growth hormone deficiency patients with different causes and to find out the role of insulin-like growth factor one in monitoring response. Methods: This retrospective study was done on fifty patients who received growth hormone for short stature due to different causes. The patients were enrolled in the study that was conducted from June 2015 to December 2015 in Helina center- Erbil. All details including history, examination, investigations, treatment and follow-up were revised. Investigations that have been sent for each patient were full blood count, thyroid function tests, bone age assessment, growth hormone stimulation and insulin like growth factor one. Follow-up for their response clinically and by investigations have been done after 3, 6 and 12 months and after two years from initiating growth hormone therapy. Patients were divided to three groups, patients on 25 mcg/kg/day therapy (Group One), patient on 30 mcg/kg/day (Group Two) and patients on 35 mcg/kg/day (Group Three). The response to growth hormone therapy of the three groups was compared. Results: Among those fifty patients, only five patients discontinued their treatment. Significant height gain was observed after two years of regular growth hormone therapy. We found that with increasing the dose of growth hormone, the patient gain more height, and had higher insulin-like growth factor one, with p<0.05 between the groups. The mean height gain over 2 years of growth hormone therapy was 11.16 cm in Group One and 16.25 cm in Group Three. Conclusions: We conclude that by giving growth hormone to short children for a period not less than two years, height will increase significantly. Giving higher allowed doses gives higher increment compared to lower doses and insulin like growth factor one is a good tool for follows-up response to therapy.
format Article
id doaj-art-67d3b3b814ee40bf82977bc7a3e2af7d
institution DOAJ
issn 2958-8979
2957-3580
language English
publishDate 2023-03-01
publisher Kurdistan Higher Council Of Medical Specialties
record_format Article
series Advanced Medical Journal
spelling doaj-art-67d3b3b814ee40bf82977bc7a3e2af7d2025-08-20T03:18:49ZengKurdistan Higher Council Of Medical SpecialtiesAdvanced Medical Journal2958-89792957-35802023-03-013210.56056/amj.2017.26131Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapyKawes Omer Zangana0Zaher Taher Gardi1Dawand Dlshad Abdulla2D.C.H, F.I.B.M.S, Assistant prof. in pediatrics,Hawler Medical University, College of MedicineCABP, Pediatrician, Raparin Pediatric Teaching HospitalKBMS, Pediatrician, Raparin Pediatric Teaching Hospital Background and objectives: To find out the response to growth hormone therapy among growth hormone deficiency patients with different causes and to find out the role of insulin-like growth factor one in monitoring response. Methods: This retrospective study was done on fifty patients who received growth hormone for short stature due to different causes. The patients were enrolled in the study that was conducted from June 2015 to December 2015 in Helina center- Erbil. All details including history, examination, investigations, treatment and follow-up were revised. Investigations that have been sent for each patient were full blood count, thyroid function tests, bone age assessment, growth hormone stimulation and insulin like growth factor one. Follow-up for their response clinically and by investigations have been done after 3, 6 and 12 months and after two years from initiating growth hormone therapy. Patients were divided to three groups, patients on 25 mcg/kg/day therapy (Group One), patient on 30 mcg/kg/day (Group Two) and patients on 35 mcg/kg/day (Group Three). The response to growth hormone therapy of the three groups was compared. Results: Among those fifty patients, only five patients discontinued their treatment. Significant height gain was observed after two years of regular growth hormone therapy. We found that with increasing the dose of growth hormone, the patient gain more height, and had higher insulin-like growth factor one, with p<0.05 between the groups. The mean height gain over 2 years of growth hormone therapy was 11.16 cm in Group One and 16.25 cm in Group Three. Conclusions: We conclude that by giving growth hormone to short children for a period not less than two years, height will increase significantly. Giving higher allowed doses gives higher increment compared to lower doses and insulin like growth factor one is a good tool for follows-up response to therapy. https://amj.khcms.edu.krd/index.php/main/article/view/130Bone ageGrowth hormone deficiencyInsulin-like growth factorShort stature
spellingShingle Kawes Omer Zangana
Zaher Taher Gardi
Dawand Dlshad Abdulla
Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy
Advanced Medical Journal
Bone age
Growth hormone deficiency
Insulin-like growth factor
Short stature
title Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy
title_full Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy
title_fullStr Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy
title_full_unstemmed Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy
title_short Variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy
title_sort variable response to growth hormone therapy in growth hormone deficient patients and role of insulin like growth factor one in monitoring response to therapy
topic Bone age
Growth hormone deficiency
Insulin-like growth factor
Short stature
url https://amj.khcms.edu.krd/index.php/main/article/view/130
work_keys_str_mv AT kawesomerzangana variableresponsetogrowthhormonetherapyingrowthhormonedeficientpatientsandroleofinsulinlikegrowthfactoroneinmonitoringresponsetotherapy
AT zahertahergardi variableresponsetogrowthhormonetherapyingrowthhormonedeficientpatientsandroleofinsulinlikegrowthfactoroneinmonitoringresponsetotherapy
AT dawanddlshadabdulla variableresponsetogrowthhormonetherapyingrowthhormonedeficientpatientsandroleofinsulinlikegrowthfactoroneinmonitoringresponsetotherapy